2023
Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System
05/31/2023
(Vancouver | May 31, 2023) Kardium Inc., a private medical device company that has developed the Globe System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first US patients have been successfully treated in the PULSAR clinical study. The PULSAR study will enroll over 400 patients for […]
Kardium announces first patients treated in PULSAR IDE study of Globe® Pulsed Field System
03/15/2023
(Vancouver, British Columbia | March 15, 2023) Kardium Inc., a private medical device company that has developed the Globe® PF System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first patients have been successfully treated in its PULSAR clinical study. The international, multicenter study recently received U.S. […]